Clinical predictors of response to interferon-β therapy in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Portaccio, E [1 ]
Zipoli, V [1 ]
Siracusa, G [1 ]
Sorbi, S [1 ]
Amato, MP [1 ]
机构：
[1] Univ Florence, Florence, Italy
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [21] Clinical characteristics of the response to β-interferon in relapsing-remitting Multiple Sclerosis from the Burgundy MS database
    Fromont, A
    Le Teuff, G
    Couvreur, G
    Dumas, R
    Giroud, M
    Quantin, C
    Moreau, T
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S238 - S238
  • [22] Clinical and Demographic Predictors of Response to First-Line Therapies in Relapsing-Remitting Multiple Sclerosis
    Castillo-Trivino, Tamara
    Gajofatto, Alberto
    Waubant, Emmanuelle
    [J]. NEUROLOGY, 2011, 76 (09) : A72 - A72
  • [23] Spotlight on Interferon-β-1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
    Paul L. McCormack
    Lesley J. Scott
    [J]. BioDrugs, 2004, 18 : 343 - 347
  • [24] Spotlight on Subcutaneous Recombinant Interferon-β-1a (Rebif®) in Relapsing-Remitting Multiple Sclerosis
    David Murdoch
    Katherine A. Lyseng-Williamson
    [J]. BioDrugs, 2005, 19 : 323 - 325
  • [25] Phase I study of oval recombinant ovine interferon-τ in relapsing-remitting multiple sclerosis
    Olek, MJ
    Smith, DR
    Cook, SL
    Khoury, SJ
    Weiner, HL
    [J]. NEUROLOGY, 2001, 56 (08) : A76 - A76
  • [26] Spotlight on subcutaneous recombinant interferon-β-1a (Rebif®) in relapsing-remitting multiple sclerosis
    Murdoch, D
    Lyseng-Williamson, KA
    [J]. BIODRUGS, 2005, 19 (05) : 323 - 325
  • [27] Long-term adherence to interferon β therapy in relapsing-remitting multiple sclerosis
    Portaccio, E.
    Zipoli, V.
    Siracusa, G.
    Sorbi, S.
    Amato, M. P.
    [J]. EUROPEAN NEUROLOGY, 2008, 59 (3-4) : 131 - 135
  • [28] Spotlight on interferon-β-1b in relapsing-remitting and secondary progressive multiple sclerosis
    McCormack, PL
    Scott, LJ
    [J]. BIODRUGS, 2004, 18 (05) : 343 - 347
  • [29] Interferon-α2a reduces MRI disease activity in relapsing-remitting multiple sclerosis
    Myhr, KM
    Riise, T
    Lilleås, FEG
    Beiske, TG
    Celius, EG
    Edland, A
    Jensen, D
    Larsen, JP
    Nilsen, R
    Nortvedt, MW
    Smievoll, AI
    Vedeler, C
    Nyland, HI
    [J]. NEUROLOGY, 1999, 52 (05) : 1049 - 1056
  • [30] Demographic and clinical predictors of response to interferon beta and glatiramer acetate as first-line treatment for relapsing-remitting multiple sclerosis
    Gajofatto, A.
    Bacchetti, E.
    Grimes, B.
    High, A.
    Moraes, C.
    Waubant, E.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S57 - S58
12345